Literature DB >> 16453339

Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD).

Paul N Baird1, Andrea J Richardson, Luba D Robman, Peter N Dimitrov, Gabriella Tikellis, Catherine A McCarty, Robyn H Guymer.   

Abstract

Progression of age-related macular degeneration (AMD), the leading cause of blindness in the elderly, was followed in a cohort of 238 individuals from a single center. Individuals with an epsilon (epsilon)2 genotype (c.526C>T of reference sequence NM_000041.2) of the apolipoprotein (APOE) gene were found to be strongly associated with disease with a significant 4.8-fold increased relative risk compared to individuals with an epsilon4 genotype (c.388T>C of reference sequence NM_000041.2) (odds ratio [OR], 4.8; 95% confidence interval [CI], 1.19-19.09) and a nearly significant three-fold increased relative risk compared to individuals with an epsilon3 genotype (reference sequence NM_000041.2) (OR, 2.8; 95% CI, 0.96-19.09). This finding was present only in females who progressed with AMD, which suggests that there may be a gender-specific role in progression of AMD in individuals with an epsilon2 allele. A gender-related factor is therefore implicated either directly or indirectly in the AMD disease process. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16453339     DOI: 10.1002/humu.20288

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  41 in total

Review 1.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

Review 2.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

Review 3.  Age-related macular degeneration.

Authors:  Tariq Ayoub; Nishal Patel
Journal:  J R Soc Med       Date:  2009-02       Impact factor: 5.344

Review 4.  Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis.

Authors:  Elaine W-T Chong; Tien Y Wong; Andreas J Kreis; Julie A Simpson; Robyn H Guymer
Journal:  BMJ       Date:  2007-10-08

5.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.

Authors:  Yi Yu; Robyn Reynolds; Jesen Fagerness; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

6.  Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes.

Authors:  Ling Shen; Thomas J Hoffmann; Ronald B Melles; Lori C Sakoda; Mark N Kvale; Yambazi Banda; Catherine Schaefer; Neil Risch; Eric Jorgenson
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

Review 7.  The proteomics of drusen.

Authors:  John W Crabb
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-05       Impact factor: 6.915

Review 8.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 9.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

Review 10.  Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration.

Authors:  Anand Swaroop; Emily Y Chew; Catherine Bowes Rickman; Gonçalo R Abecasis
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.